BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
Bravo
If ARM was an arm, BRN would be its biceps💪!
Time for a reality check, methinks.
I know many of us are hoping AKIDA might be featured in the upcoming Nintendo Switch 2 and believe me, I’d love to be proven wrong about this, but based on what we know so far, I’m 99% sure it’s not happening.
For starters, Sean’s own comments about royalties being "unlikely" this year are pretty telling.
Secondly, based on leaked specs and early hands-on impressions, there’s no evidence that the new "C button" or other system features require the kind of neuromorphic processing that AKIDA specialises in. In fact, the Switch 2’s battery life is reportedly only a few hours which is not ideal for showcasing one of AKIDA's biggest selling points - ultra-low power efficiency.
I hope I'm wrong, but until we see something more concrete...
Last edited:
smoothsailing18
Regular
Megachip haven't ever revealed its customers apart from Nintendo, however they have said they are suppling one of the top two camera companies in Japan whom are.....
Canon and Sony, so may be this is were we are involved if not in nintendo.
Canon and Sony, so may be this is were we are involved if not in nintendo.
Bravo
If ARM was an arm, BRN would be its biceps💪!
Thanks for posting Pom!
From a quick preview, MegaChips’ latest financial report for FY2024 (ended March 2025) seems to outline their ambitions and alignment with Morse Micro in clear terms, including references to the partnership and its commercial prospects.
By contrast, there’s no mention whatsoever of BrainChip or neuromorphic computing in the report. A bit weird, especially considering that both Quadric, Morse Micro and BrainChip were brought under MegaChips' strategic purview around the same time, weren't they??
Why is Morse Micro front and centre in their investor communications in this report, while BrainChip is absent?
Is it a matter of strategic secrecy? If that were the case, why wouldn’t they treat Morse Micro with the same level of discretion?
On the other hand, one could reasonably infer that Morse Micro is being highlighted because it is being actively commercialised, whereas BrainChip may not be for reasons that remain unclear. Whether it’s a matter of technical readiness, market timing, etc, the contrast in how the two partnerships are presented is hard to ignore.
BTW, I don't know the answers to any of the above questions.
Last edited:
Frangipani
Top 20
Interesting comment under Tony Dawe’s farewell post on LinkedIn:
www.linkedin.com
While I can’t comment on the veracity of Matthew R.’s statement that Tony Dawe did “a great job at BRN with engaging with DACH* investors as company sees strong volumes on DE** exchanges”…
*DACH is an acronym encompassing the three neighbouring countries with the largest German-speaking population in Europe, derived from their international vehicle registration codes, namely Germany (D), Austria (A) and Switzerland (CH = Confoederatio Helvetica). In English, the term GSA is sometimes used (Germany, Switzerland, Austria).
** DE = Deutschland, so it refers to the Germany-based exchanges where BRN can be traded
… I wonder whether Matthew R. (Reynolds) is
a) just a fellow BRN retail shareholder,
b) someone who has a professional interest in getting the attention of BRN for future collaboration with the company he works for (so far BRN is neither listed as a client of Frankfurt am Main-based Dr. Reuter Investor Relations nor has it been promoted by Matthew Reynolds on LinkedIn in recent weeks, unlike other companies have - but why then comment under a post of an employee who is about to leave the company?),
or c) someone who’s already been in contact with BRN behind the scenes, possibly even in relation to evaluating a dual listing on the ASX and the Frankfurt Stock Exchange?
It struck me as somewhat odd that Tony Dawe didn’t address him by name in his reply, as he did with the others wishing him well - which seems to suggest a more distanced relationship, if there exists any at all.
Nevertheless, Matthew Reynold’s LinkedIn profile caught my eye, given Antonio J. Viana was quoted as having mentioned during the AGM that BrainChip were evaluating to investigate a potential redomicile not only to the US (as per the 27 February 2025 ASX Announcement, the wording of which our Chairman of the Board shockingly seemed to be unaware of) but also to other regions. And according to Viana, one of these could apparently also be Europe.
Saying that, I am not sure how exactly a potential dual listing at let’s say the Frankfurt Stock Exchange would benefit BRN, as both institutional as well as retail shareholders in Europe can already invest in BRN without a problem.
Instead, it’s the US-based investors who currently have to pay a premium for investing in ASX-only-listed stocks, and the US market “provides access to a substantially larger and highly technologically sophisticated pool of potential investors on a global scale” our company said it was hoping to target.
(Although brokers here in Germany don’t provide BRN shareholders with an invitation to the AGM or voter access codes etc free of charge, so that might change for the better?)
I noted that as of 28 April 2025, BNP Paribas Nominees Pty Ltd < Clearstream> (Clearstream is a wholly-owned subsidiary of Deutsche Börse Group) is now the second biggest entity in the TOP 50 with 125,490,690 shares, after Peter van der Made’s holdings that amounted to 156,805,823 shares.
Compare that to the Top 50 released on 28 April 2024, in which the BNP Paribas Clearstream nominee account held “only” 107,109,511 shares. More accumulation has evidently happened from end of April 2024 to end of April 2025, although we don’t know by whom exactly.
Anyway, BRN appears to have a comparatively large European institutional investor base already.
Am I overlooking something here?
www.dr-reuter.eu
This week marks the end of my four year tenure as Director, Global… | Tony Dawe, GAICD | 54 comments
This week marks the end of my four year tenure as Director, Global Investor Relations at Brainchip. My position has been made redundant and I leave with a sense of optimism for my future. I wish the Board, employees and 46,000 passionate BRN shareholders all the very best. I wanted to...
While I can’t comment on the veracity of Matthew R.’s statement that Tony Dawe did “a great job at BRN with engaging with DACH* investors as company sees strong volumes on DE** exchanges”…
*DACH is an acronym encompassing the three neighbouring countries with the largest German-speaking population in Europe, derived from their international vehicle registration codes, namely Germany (D), Austria (A) and Switzerland (CH = Confoederatio Helvetica). In English, the term GSA is sometimes used (Germany, Switzerland, Austria).
** DE = Deutschland, so it refers to the Germany-based exchanges where BRN can be traded
… I wonder whether Matthew R. (Reynolds) is
a) just a fellow BRN retail shareholder,
b) someone who has a professional interest in getting the attention of BRN for future collaboration with the company he works for (so far BRN is neither listed as a client of Frankfurt am Main-based Dr. Reuter Investor Relations nor has it been promoted by Matthew Reynolds on LinkedIn in recent weeks, unlike other companies have - but why then comment under a post of an employee who is about to leave the company?),
or c) someone who’s already been in contact with BRN behind the scenes, possibly even in relation to evaluating a dual listing on the ASX and the Frankfurt Stock Exchange?
It struck me as somewhat odd that Tony Dawe didn’t address him by name in his reply, as he did with the others wishing him well - which seems to suggest a more distanced relationship, if there exists any at all.
Nevertheless, Matthew Reynold’s LinkedIn profile caught my eye, given Antonio J. Viana was quoted as having mentioned during the AGM that BrainChip were evaluating to investigate a potential redomicile not only to the US (as per the 27 February 2025 ASX Announcement, the wording of which our Chairman of the Board shockingly seemed to be unaware of) but also to other regions. And according to Viana, one of these could apparently also be Europe.
Saying that, I am not sure how exactly a potential dual listing at let’s say the Frankfurt Stock Exchange would benefit BRN, as both institutional as well as retail shareholders in Europe can already invest in BRN without a problem.
Instead, it’s the US-based investors who currently have to pay a premium for investing in ASX-only-listed stocks, and the US market “provides access to a substantially larger and highly technologically sophisticated pool of potential investors on a global scale” our company said it was hoping to target.
(Although brokers here in Germany don’t provide BRN shareholders with an invitation to the AGM or voter access codes etc free of charge, so that might change for the better?)
I noted that as of 28 April 2025, BNP Paribas Nominees Pty Ltd < Clearstream> (Clearstream is a wholly-owned subsidiary of Deutsche Börse Group) is now the second biggest entity in the TOP 50 with 125,490,690 shares, after Peter van der Made’s holdings that amounted to 156,805,823 shares.
Compare that to the Top 50 released on 28 April 2024, in which the BNP Paribas Clearstream nominee account held “only” 107,109,511 shares. More accumulation has evidently happened from end of April 2024 to end of April 2025, although we don’t know by whom exactly.
Anyway, BRN appears to have a comparatively large European institutional investor base already.
Am I overlooking something here?
About -eng – Dr. Reuter Investor Relations
www.dr-reuter.eu
Attachments
Last edited:
CHIPS
Regular
Interesting comment under Tony Dawe’s farewell post on LinkedIn:
This week marks the end of my four year tenure as Director, Global… | Tony Dawe, GAICD | 54 comments
This week marks the end of my four year tenure as Director, Global Investor Relations at Brainchip. My position has been made redundant and I leave with a sense of optimism for my future. I wish the Board, employees and 46,000 passionate BRN shareholders all the very best. I wanted to...
View attachment 86571
While I can’t comment on the veracity of Matthew R.’s statement that Tony Dawe did “a great job at BRN with engaging with DACH* investors as company sees strong volumes on DE** exchanges”…
*DACH is an acronym encompassing the three neighbouring countries with the largest German-speaking population in Europe, derived from their international vehicle registration codes, namely Germany (D), Austria (A) and Switzerland (CH = Confoederatio Helvetica). In English, the term GSA is sometimes used (Germany, Switzerland, Austria).
** DE = Deutschland, so it refers to the Germany-based exchanges where BRN can be traded
… I wonder whether Matthew R. (Reynolds) is
a) just a fellow BRN retail shareholder,
b) someone who has a professional interest in getting the attention of BRN for future collaboration with the company he works for (so far BRN is neither listed as a client of Frankfurt am Main-based Dr. Reuter Investor Relations nor has it been promoted by Matthew Reynolds on LinkedIn in recent weeks, unlike other companies have - but why then comment under a post of an employee who is about to leave the company?),
or c) someone who’s already been in contact with BRN behind the scenes, possibly even in relation to evaluating a dual listing on the ASX and the Frankfurt Stock Exchange?
It struck me as somewhat odd that Tony Dawe didn’t address him by name in his reply, as he did with the others wishing him well - which seems to suggest a more distanced relationship, if there exists any at all.
Nevertheless, Matthew Reynold’s LinkedIn profile caught my eye, given Antonio J. Viana was quoted as having mentioned during the AGM that BrainChip were evaluating to investigate a potential redomicile not only to the US (as per the 27 February 2025 ASX Announcement, the wording of which our Chairman of the Board shockingly seemed to be unaware of) but also to other regions. And according to Viana, one of these could apparently also be Europe.
Saying that, I am not sure how exactly a potential dual listing at let’s say the Frankfurt Stock Exchange would benefit BRN, as both institutional as well as retail shareholders in Europe can already invest in BRN without a problem.
Instead, it’s the US-based investors who currently have to pay a premium for investing in ASX-only-listed stocks, and the US market “provides access to a substantially larger and highly technologically sophisticated pool of potential investors on a global scale” our company said it was hoping to target.
(Although brokers here in Germany don’t provide BRN shareholders with an invitation to the AGM or voter access codes etc free of charge, so that might change for the better?)
I noted that as of 28 April 2025, BNP Paribas Nominees Pty Ltd < Clearstream> (Clearstream is a wholly-owned subsidiary of Deutsche Börse Group) is now the second biggest entity in the TOP 50 with 125,490,690 shares, after Peter van der Made’s holdings that amounted to 156,805,823 shares.
Compare that to the Top 50 released on 28 April 2024, in which the BNP Paribas Clearstream nominee account held “only” 107,109,511 shares. More accumulation has evidently happened from end of April 2024 to end of April 2025, although we don’t know by whom exactly.
Anyway, BRN appears to have a comparatively large European institutional investor base already.
Am I overlooking something here?
View attachment 86572 View attachment 86573 View attachment 86574 View attachment 86575
About -eng – Dr. Reuter Investor Relations
View attachment 86585
Perhaps Matthew had met Tony on the occasion of representing a major stockholder?
Quiltman
Regular
Interesting article, the end of Untether AI.
#brainchip #edgeai #akida #raspberrypi #ai #innovation | BrainChip
Check out our new website at https://www.brainchip.com. The newly designed site offers a range of enhancements aimed at improving user experience, providing comprehensive information on our products and technologies, and showcasing the many use cases that can benefit from our on-device Edge AI...
Frangipani
Top 20
Akida gets a mention alongside other neuromorphic platforms in this newly published paper titled “Spiking Neural Networks for Multimodal Neuroimaging: A Comprehensive Review of Current Trends and the NeuCube Brain-Inspired Architecture”, co-authored by researchers from various New Zealand 
research entities. The paper is based on data obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database and concludes that “SNNs offer a viable approach to addressing some of the limitations of traditional ANNs in multimodal neuroimaging, particularly in processing spatiotemporal data, such as EEG and fMRI”, although it also states that challenges remain.
(…)
(…)
(…)
(…)
One of the papers referenced
is the Uni Tübingen table tennis robot paper (that involved Akida), which first author Andreas Ziegler recently presented at the International Conference on Robotics and Automation (ICRA 2025) in Atlanta:
research entities. The paper is based on data obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database and concludes that “SNNs offer a viable approach to addressing some of the limitations of traditional ANNs in multimodal neuroimaging, particularly in processing spatiotemporal data, such as EEG and fMRI”, although it also states that challenges remain.(…)
(…)
(…)
(…)
One of the papers referenced
is the Uni Tübingen table tennis robot paper (that involved Akida), which first author Andreas Ziegler recently presented at the International Conference on Robotics and Automation (ICRA 2025) in Atlanta:Hopefully, Andreas Ziegler from Uni Tübingen will have an appreciative audience game for some event-(camera)-ful table tennis talk
He will be presenting his team’s research (which also involved Akida and was partially funded by Sony AI, where he was a Research Scientist Intern at their office in Switzerland from November 2023 to March 2024 as part of his ongoing PhD studies at Uni Tübingen) that led to the publication of the
Detection of Fast-Moving Objects with Neuromorphic Hardware | Andreas Ziegler
#ICRA2025 is coming closer! I’ll be presenting our work, “Detection of Fast-Moving Objects with Neuromorphic Hardware” — more details here: https://lnkd.in/ew-U5-BD I was also accepted into the Doctoral Consortium (DC), where I’ll present my research on event-based vision for fast robot...
View attachment 84958
View attachment 84959
View attachment 84960
It is worthwhile to refresh our memories regarding the whereabouts of his co-authors Sebastian Otte and Karl Vetter, who are both Uni Tübingen alumni from the same Cognitive Systems research group, where Andreas Ziegler is currently pursuing his PhD (https://uni-tuebingen.de/fakultaete...che/informatik/lehrstuehle/kognitive-systeme/):
Attachments
Dave Evans
Regular
The bots and spammers were reported by multiple AVZ members for the last three weeks. Now more than 50 long term AVZ contributors have left the thread because nothing was done and the long term contributors posts kept vanishing off the thread. AVZ was the second biggest contributor to TSE.
PS I know this isn’t BRN related. It’s TSE related and I’m just replying to your previous reply.
supersonic001
Regular
#brainchip #edgeai #akida #raspberrypi #ai #innovation | BrainChip
Check out our new website at https://www.brainchip.com. The newly designed site offers a range of enhancements aimed at improving user experience, providing comprehensive information on our products and technologies, and showcasing the many use cases that can benefit from our on-device Edge AI...
Upgrade the Raspberry Pi for AI with a Neuromorphic Processor
Upgrade the Raspberry Pi for AI with a Neuromorphic Processor Chris Anastasi, Applications Engineer Raspberry Pi developers, makers and hobbyists interested in creating Edge AI use cases need to look no further than the BrainChip
brainchip.com
Jacob Kiraz
Member
I thought Brn used to say they don't know what companies do once signed a IP License
Just opened my Nintendo 2 and I can confirm that Brainchip is in it!
It even has a training package for users.
I have no idea how to use these things, but very nice surprise! Can't believe there was no asx announcement
Happy with the purchase. Highly recommend JB Hi-fi Parramatta. Very helpful staff that knows there stuff!
Akida forever!
Not advice
It even has a training package for users.
I have no idea how to use these things, but very nice surprise! Can't believe there was no asx announcement
Happy with the purchase. Highly recommend JB Hi-fi Parramatta. Very helpful staff that knows there stuff!
Akida forever!
Not advice
What made you to come to that conclusion. Any proof.Just opened my Nintendo 2 and I can confirm that Brainchip is in it!
It even has a training package for users.
I have no idea how to use these things, but very nice surprise! Can't believe there was no asx announcement
Happy with the purchase. Highly recommend JB Hi-fi Parramatta. Very helpful staff that knows there stuff!
Akida forever!
Not advice
And on LinkedIn
www.linkedin.com
#brainchip #edgeai #akida #raspberrypi #ai #innovation | BrainChip
Check out our new website at https://www.brainchip.com. The newly designed site offers a range of enhancements aimed at improving user experience, providing comprehensive information on our products and technologies, and showcasing the many use cases that can benefit from our on-device Edge AI...
TheDrooben
Pretty Pretty Pretty Pretty Good
DingoBorat
Slim
Similar threads
